BHNG — Bhang Income Statement
0.000.00%
Last trade - 00:00
HealthcareSpeculativeMicro Cap
2017 September 30th | 2018 September 30th | R2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 4.63 | 1.63 | 1.27 |
Cost of Revenue | |||||
Gross Profit | — | — | -0.539 | 0.909 | 0.842 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -0.119 | -0.016 | 17.7 | 5.97 | 4.24 |
Operating Profit | 0.119 | 0.016 | -13.1 | -4.34 | -2.98 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.105 | 0.086 | -13.4 | -4.42 | -3.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.105 | 0.086 | -13.4 | -4.42 | -3.3 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.105 | 0.086 | -15.1 | -4.42 | -3.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.105 | 0.086 | -15.1 | -4.42 | -3.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.048 | -0.005 | -0.089 | -0.023 | -0.017 |